Electrochemical Simulation of Phase I Metabolism for 21 Drugs Using Four Different Working Electrodes in an Automated Screening Setup with MS Detection

References

• Shono T , TodaT, OshinoN. Preparation of N-dealkylated drug metabolites by electrochemical simulation of biotransformation. Drug Metab. Dispos. 9 (5), 481–481 (1981).
   PubMed Web of Science ®Google Scholar
• Faber H , MellesD, BrauckmannC, WeheCA, WentkerK, KarstU. Simulation of the oxidative metabolism of diclofenac by electrochemistry/(liquid chromatography/)mass spectrometry. Anal. Bioanal. Chem. 403 (2), 345–354 (2012).
   PubMed Web of Science ®Google Scholar
• Jahn S , BaumannA, RoscherJ, HenseK, ZazzeroniR, KarstU. Investigation of the biotransformation pathway of verapamil using electrochemistry/liquid chromatography/mass spectrometry – a comparative study with liver cell microsomes. J. Chromatogr. A1218 (51), 9210–9220 (2011).
   PubMed Web of Science ®Google Scholar
• Johansson T , WeidolfL, JurvaU. Mimicry of phase I drug metabolism – novel methods for metabolite characterization and synthesis. Rapid Commun. Mass Spectrom. 21 (14), 2323–2331 (2007).
   PubMed Web of Science ®Google Scholar
• Baumann A , LohmannW, SchubertB, OberacherH, KarstU. Metabolic studies of tetrazepam based on electrochemical simulation in comparison to in vivo and in vitro methods. J. Chromatogr. A1216 (15), 3192–3198 (2009).
   PubMed Web of Science ®Google Scholar
• Jurva U , WikstromHV, WeidolfL, BruinsAP. Comparison between electrochemistry/mass spectrometry and cytochrome P450 catalyzed oxidation reactions. Rapid Commun. Mass Spectrom. 17 (8), 800–810 (2003).
   PubMed Web of Science ®Google Scholar
• Baumann A , KarstU. Online electrochemistry/mass spectrometry in drug metabolism studies: principles and applications. Expert Opin. Drug Metab. Toxicol. 6 (6), 715–731 (2010).
   PubMed Web of Science ®Google Scholar
• Kraemer T , MaurerHH. Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives. Ther. Drug Monit. 24 (2), 277–289 (2002).
   PubMed Web of Science ®Google Scholar
• Meyer MR , WilhelmJ, PetersFT, MaurerHH. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Anal. Bioanal. Chem. 397 (3), 1225–1233 (2010).
   PubMed Web of Science ®Google Scholar
• Pedersen AJ , ReitzelLA, JohansenSS, LinnetK. In vitro metabolism studies on mephedrone and analysis of forensic cases. Drug Test. Anal. 5 (6), 430–438 (2013).
   PubMed Web of Science ®Google Scholar
• Pedersen AJ , PetersenTH, LinnetK. In vitro metabolism and pharmacokinetic studies on methylone. Drug Metab. Dispos. 41 (6), 1247–1255 (2013).
   PubMed Web of Science ®Google Scholar
• Makino Y , HiguchiT, OhtaS, HirobeM. Identification and quantification of p-hydroxyethylamphetamine as a novel metabolite of ethylamphetamine in rat by gas chromatography–mass spectrometry. Forensic Sci. Int. 41 (1–2), 83–91 (1989).
   PubMed Web of Science ®Google Scholar
• Bach MV , CouttsRT, BakerGB. Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives. Xenobiotica29 (7), 719–732 (1999).
   PubMed Web of Science ®Google Scholar
• Sitaram BR , TalomsinR, BlackmanGL, McLeodWR. Study of metabolism of psychotomimetic indolealkylamines by rat tissue extracts using liquid chromatography. Biochem. Pharmacol. 36 (9), 1503–1508 (1987).
   PubMed Web of Science ®Google Scholar
• Kanamori T , KuwayamaK, TsujikawaK, MiyaguchiH, IwataYT, InoueH. In vivo metabolism of alpha-methyltryptamine in rats: identification of urinary metabolites. Xenobiotica38 (12), 1476–1486 (2008).
   PubMed Web of Science ®Google Scholar
• Shen HW , WuC, JiangXL, YuAM. Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N, N-dimethyltryptamine metabolism and pharmacokinetics. Biochem. Pharmacol. 80 (1), 122–128 (2010).
   PubMed Web of Science ®Google Scholar
• Wohlfarth A , ScheidweilerKB, ChenX, LiuHF, HuestisMA. Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC–MS/MS and library search. Anal. Chem. 85 (7), 3730–3738 (2013).
   PubMed Web of Science ®Google Scholar
• Hutter M , BroeckerS, KneiselS, AuwarterV. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in ‘herbal mixtures’ using LC–MS/MS techniques. J. Mass Spectrom. 47 (1), 54–65 (2012).
   PubMed Web of Science ®Google Scholar
• Chimalakonda KC , MoranCL, KennedyPDet al. Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine. Anal. Chem. 83 (16), 6381–6388 (2011).
   PubMed Web of Science ®Google Scholar
• Grigoryev A , KavanaghP, MelnikA. The detection of the urinary metabolites of 3-[(adamantan-1-yl)carbonyl]-1-pentylindole (AB-001), a novel cannabimimetic, by gas chromatography–mass spectrometry. Drug Test. Anal. 4 (6), 519–524 (2012).
   PubMed Web of Science ®Google Scholar
• Moller I , WintermeyerA, BenderKet al. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Test. Anal. 3 (9), 609–620 (2011).
   PubMed Web of Science ®Google Scholar
• Zhang Q , MaP, ColeRB, WangGD. Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC–MS/MS. Anal. Bioanal. Chem. 386 (5), 1345–1355 (2006).
   PubMed Web of Science ®Google Scholar
• Nouri-Nigjeh E , PermentierHP, BischoffR, BruinsAP. Lidocaine oxidation by electrogenerated reactive oxygen species in the light of oxidative drug metabolism. Anal. Chem. 82 (18), 7625–7633 (2010).
   PubMed Web of Science ®Google Scholar
• Lohmann W , MeermannB, MollerI, SchefferA, KarstU. Quantification of electrochemically generated iodine-containing metabolites using inductively coupled plasma mass spectrometry. Anal. Chem. 80 (24), 9769–9775 (2008).
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) . New drugs in Europe (2012). www.emcdda.europa.eu/publications/implementation-reports/2012
   Google Scholar
• Auwarter V , DresenS, WeinmannW, MullerM, PutzM, FerreirosN. ’spice’ and other herbal blends: harmless incense or cannabinoid designer drugs?J. Mass. Spectrom. 44 (5), 832–837 (2009).
   PubMed Web of Science ®Google Scholar
• Lohmann W , KarstU. Biomimetic modeling of oxidative drug metabolism: strategies, advantages and limitations. Anal. Bioanal. Chem. 391 (1), 79–96 (2008).
   PubMed Web of Science ®Google Scholar
• Corkery JM , DurkinE, ElliottS, SchifanoF, GhodseAH. The recreational tryptamine 5-MeO-DALT (N, N-diallyl-5-methoxytryptamine): a brief review. Prog. Neuropsychopharmacol. Biol. Psychiatry39 (2), 259–262 (2012).
   PubMed Web of Science ®Google Scholar
• Mazzarino M , BiavaM, de la TorreX, FiaccoI, BotreF. Characterization of the biotransformation pathways of clomiphene, tamoxifen and toremifene as assessed by LC–MS/(MS) following in vitro and excretion studies. Anal. Bioanal. Chem. 405 (16), 5467–5487 (2013).
   PubMed Web of Science ®Google Scholar
• Shayeganpour A , El-KadiAO, BrocksDR. Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: the contribution of cytochrome P450 3A isoforms. Drug Metab. Dispos. 34 (1), 43–50 (2006).
   PubMed Web of Science ®Google Scholar
• Simon H , MellesD, JacquoilleotS, SandersonP, ZazzeroniR, KarstU. Combination of electrochemistry and nuclear magnetic resonance spectroscopy for metabolism studies. Anal. Chem. 84 (20), 8777–8782 (2012).
   PubMed Web of Science ®Google Scholar